| Financial Year |
March 31 2023 |
| Monetary Funds |
98,745,299.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
40,059,246.92 |
| Advances to Suppliers |
18,055,240.79 |
| Other Receivables |
2,710,482.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,265,547.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
683,851.03 |
| Total Current Assets |
259,264,241.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
329,738,313.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,122,012.74 |
| R&D expenses |
5,175,230.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,007,635.37 |
| Deferred Income Tax Assets |
6,669,976.64 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
417,137,838.62 |
| Total Assets |
676,402,080.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
28,338,453.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,631,068.35 |
| Taxes Payable |
6,692,363.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,044,495.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,220,923.58 |
| Other Current Liabilities |
968,245.10 |
| Sub-Total of Current Liabilities |
60,559,509.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
85,312,959.14 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
127,220,254.88 |
| Total Liabilities |
187,779,764.23 |
| Paid-In Capital(Or Share Stock) |
1,276,780,727.00 |
| Capital Surplus |
830,352,338.84 |
| Surplus Reserve |
23,326,052.58 |
| LESS:Treasury Stock |
92,515,957.24 |
| Undistributed Profits |
-1,518,303,067.65 |
| Minority Stockholder's Interest |
-1,017,777.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
489,640,093.53 |
| Owner's Equity（Stockholder's Equity） |
488,622,316.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
676,402,080.36 |
